CRISPR Therapeutics (CRSP) Q1 2025 Earnings

11FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.49
-1.14
-0.79
-0.44

Details

Expected EPS
-1.200644
Actual EPS
-0.44
Surprise EPS
0.76
Surprise Percent
+63.35%

Description

CRISPR Therapeutics (CRSP) has reported earnings of -0.44 per share for Q1 2025.

0 Comments

Share your thoughts